Latest News Archive
Please select Category, Year, and then Month to display items
17 October 2024
|
Story Precious Shamase
|
Photo Supplied
Sibahle Mabaso during her BA (Hons) Drama and Theatre Arts (2022) graduation, which she passed cum laude.
Sibahle Mabaso, a talented and driven individual, has been making waves at the University of the Free State (UFS). As a runner-up in the prestigious Siyaphumelela ATD DREAM Scholar programme, Mabaso's dedication and achievements have not gone unnoticed.
A multi-faceted student, Mabaso excelled in both her academic pursuits and extracurricular activities. A graduate of the UFS Drama and Theatre Arts programme, Mabaso's academic pursuits have been as diverse as her interests. She has a BA in Drama and Theatre Arts (2019-2021), a BA Honours in Drama and Theatre Arts (2022), and she is currently pursuing a Master of Arts with specialisation in Gender Studies. Her passion for the arts is evident in her work as a playwright, director, and educator. Mabaso is currently an Assistant Researcher in Transition, Development and Success within the Centre for Teaching and Learning.
Mabaso's journey to academic success has been marked by resilience and perseverance. Despite facing challenges, she has overcome obstacles through hard work, determination, and the support of mentors.
Beyond her academic achievements, Mabaso is committed to giving back to her community. She recently founded a creative enterprise called Wild Geese PTY LTD, which aims to provide opportunities for young creatives. Through her work, Mabaso hopes to inspire and mentor others, sharing her experiences and knowledge to help them reach their full potential.
As Mabaso continues her academic journey and pursues her career goals, her dedication and passion for both her studies and community engagement are sure to inspire others. Her achievements serve as a testament to the power of hard work, resilience, and a commitment to making a positive impact. Looking ahead, Mabaso hopes to continue her academic pursuits and pursue a career in higher education. She is also passionate about giving back to her community and mentoring young people. With her talent, dedication, and unwavering spirit, there is no doubt that Sibahle Mabaso will continue to achieve great things.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004